Amaranthus viridis Linn., a common spinach, modulates C-reactive protein, protein profile, ceruloplasmin and glycoprotein in experimental induced myocardial infarcted rats

Journal of the Science of Food and Agriculture

Volumn 92, Issue 12, 2012, Pages 2459-2464

  Saravanan, Ganapathy ^a   Ponmurugan, Ponnusamy ^b  

^a K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

^b K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

Author keywords

C reactive protein; Glycoprotein; Isoproterenol

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; GLYCOPROTEIN; ISOPRENALINE; PLANT EXTRACT; PLASMA PROTEIN; SERUM ALBUMIN; SERUM GLOBULIN;

AMARANTHUS; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; HEART INFARCTION; MALE; METABOLISM; PHYTOTHERAPY; RAT; WISTAR RAT;

AMARANTHUS; ANIMALS; BLOOD PROTEINS; C-REACTIVE PROTEIN; CERULOPLASMIN; GLYCOPROTEINS; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SERUM ALBUMIN; SERUM GLOBULINS;

AMARANTHUS VIRIDIS; RATTUS; RATTUS NORVEGICUS; SPINACIA OLERACEA;

EID: 84864813016     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.5652     Document Type: Article

References (39)

1. Chockalingam A, Ganeshan N and Venkatesan S, Patterns and predictors of prehypertension among healthy urban adults in India. Angiology 56: 557-563 (2005).
2. Ganesan B, Buddhan ES and Anandan R, Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. Mol Biol Rep 37: 1319-1327 (2010).
3. Sangeetha T and Darlin Quine S, Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats. J Appl Toxicol 28: 710-716 (2008).
4. Cooper R, Cutler J, Desvignes-Nickens P, Fortmann SP, Friedman L, Havlik R, et al, Trends and disparities in coronary heart disease, stroke, and other cardiovascular disease in the United States; findings of the National Conference on Cardiovascular Disease Prevention. Circulation 102: 3137-3147 (2000).
5. Wexler BC, Myocardial infarction in young vs. old male rats: pathophysiologic changes. Am Heart J 96: 70-80 (1978).
6. Nirmala C and Puvanakrishnan R, Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159: 85-93 (1996).
7. Alpert JS, Thygesen K, Antman E and Bassand JP, Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36: 959-969 (2000).
8. Banerjee SK and Maulik SK, Effect of garlic on cardiovascular disorders: a review. Nutr J 19: 4-8 (2002).
9. Turin M, Ethnobotanical notes on Thangmi plant names and their medicinal and ritual uses. Contrib Nepal Stud 30: 1-7 (2003).
10. Hunter KJ and Fletcher JM, The antioxidant activity and composition of fresh, frozen, jarred and canned vegetables. Innovat Food Sci Emerg Technol 3: 399-406 (2002).
11. Ashok Kumar BR, Lakshman K and Jayaveera JN, Estimation of rutin and quercetin in Amaranthus viridis Linn by HPLC. Asian J Exp Sci 23: 51-54 (2009).
12. Ashok Kumar BS, Lakshman K, Jayaveea KN, Sheshadri Shekar D, Khan S, Thippeswamy BS, et al, Antidiabetic, antihyperlipidemic and antioxidant activities of methanolic extract of Amaranthus viridis Linn in alloxan induced diabetic rats. Exp Toxicol Pathol 50: 394-413 (2010). DOI: 10.1016/j.etp.2010.06.009.
13. Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S and Sengottuvelu S, Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol DOI: 10.1016/j.ijcard.2011.09.005 (in press).
14. Saravanan G and Prakash J, Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 94: 155-158 (2004).
15. Niebes P, Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin Chim Acta 42: 399-408 (1972).
16. Wagner WD, A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem 94: 394-396 (1979).
17. Warren L, The thiobarbituric acid assay of sialic acids. J Biol Chem 234: 1971-1975 (1959).
18. Dische Z and Shettles LB, A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 175: 595-603 (1948).
19. Ridker PM, Hennekens CH, Buring JE and Rifai N, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med 342: 836-843 (2000).
20. Lind L, Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169: 203-214 (2003).
21. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, et al, Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol 47: 962-968 (2006).
22. Cusack MR, Marber MS, Lambiase PD, Bucknall CA and Redwood SR, Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 39: 1917-1923 (2002).
23. Ueda S, Ikeda U and Yamamoto K, C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 131: 857-860 (1996).
24. Merino A, Artaiz M and Alinz I, Eptifibatide blocks the increase in C-reactive protein levels induced by coronary angioplasty. European Society of Cardiology Congr., Berlin, pp. 185-196 (2002).
25. Klonoff-Cohen H, Barrett-Connor EL and Edelstein SL, Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol 45: 207-212 (1992).
26. Schalk BWM, Visser M, Bremmer MA, Penninx BWJH, Bouter LM and Deeg DJH, Change of serum albumin and risk of cardiovascular disease and all-cause mortality. Am J Epidemiol 164: 969-977 (2006).
27. Shearman CP, Gosling P, Gwynn BR and Simms MH, Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur J Vasc Surg 2: 401-404 (1988).
28. Esterbauer H, Striegl G, Puhl H and Rotheneder M, Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6: 67-75 (1989).
29. Cousins RJ, Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 65: 238-309 (1985).
30. Mateescu MA, Chahine R, Roger S, et al, Protection of myocardial tissue against deleterious effects of oxygen free radicals by ceruloplasmin. Arzneimittelforschung 45: 476-480 (1995).
31. Moczar M and Moczar E, Glycoproteins from the aorta. Pathol Biol 26: 63-69 (1978).
32. Tandon SK, Solanki RL, Ramdeo IN, Anand VK and Singh U, A study of serum glycoprotein in cardiovascular disorders. Indian J Med Res 37: 223-225 (1983).
33. Mukesh N, Ojha1 SK and Ranjit K, Changes in levels of serum glycoproteins in major depressive disorders. Indian J Clin Biochem 20: 154-157 (2005).
34. Radhakrishnanamoorhy B, Berenson GS and Pargaonkar PS, Serum free and protein bound sugars and cardiovascular complications. Lab Invest 34: 159-165 (1976).
35. Rajadurai M and Stanely Mainzen Prince P, Preventive effect of naringin on isoproterenol induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology 232: 216-225 (2007).
36. Crook MA, Sialic acid and cardiovascular disease. Med Biochem 1: 123-130 (1999).
37. Schauer R, Sialic acids and their role as biological masks. Trends Biochem Sci 10: 357-360 (1985).
38. Pickup JC and Crook MA, Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248 (1998).
39. Born GV and Palinski W, Unusually high concentration of sialic acid on the surface of vascular endothelium. Br J Exp Pathol 66: 543-549 (1985).